Vaginal micronized progesterone capsules for the prevention of miscarriage and preterm birth a review of the clinical evidence
The purpose of this report is to review the available evidence on the clinical efficacy and safety of vaginally administered micronized progesterone capsules for the prevention of miscarriage and preterm birth
Corporate Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
[Ottawa, Ontario]
Canadian Agency for Drugs and Technologies in Health
2014, 28 April 2014
|
Series: | Rapid response report : summary with critical appraisal
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The purpose of this report is to review the available evidence on the clinical efficacy and safety of vaginally administered micronized progesterone capsules for the prevention of miscarriage and preterm birth |
---|---|
Item Description: | Title from PDF caption title |
Physical Description: | 1 PDF file (18 pages) illustrations |